IP Library Granted Patent US 8,987,430
Granted Patent B2
US 8,987,430 · App. 13/791,178 · Granted Mar 24, 2015

Efficient and scalable process for the manufacture of fondaparinux sodium

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,987,430
App. No.
13/791,178
Granted
Mar 24, 2015
Kind
B2
Abstract

The present invention relates to a process for the synthesis of the Factor Xa anticoagulent Fondaparinux and related compounds. The invention relates, in addition, to efficient and scalable processes for the synthesis of various intermediates useful in the synthesis of Fondaparinux and related compounds.

Claims (20)

1. A process for the preparation of a monosaccharide AMod3 having the structure

comprising anhydro ring opening and acetylating the monomer IntA5 having the structure

to form a compound AMod 1 having the structure

and α-methylglycosylating the monomer AMod1 to form the monomer AMod3.

2. A process for the preparation of Fondaparinux sodium compound IntB1 having the structure

comprising the step of:

(a) benzylating the compound SM-B having the structure

3. The process of claim 2 , further comprising the steps:

(i) selectively hydrolyzing the compound IntB1 to form a compound IntB2 having the structure

(ii) oxidatively cleaving the 5,6 dihydroxy group of the compound IntB2 to form a compound IntB3 having the structure

(iii) reacting the compound IntB3 with tris(phenylthio) methane to form a compound IntB4 having the structure

(iv) esterifying the compound IntB4 to form a compound IntB5 having the structure

(v) cleaving the 1,2-isopropylidene group of the compound IntB5 to form a compound IntB6 having the structure

and

(vi) reacting the compound IntB6 with 2-methoxy propene to form Monomer B-1 having the structure

4. A process for preparing EDC-Trimer-CB of the formula

comprising the steps:

(a) coupling an E monomer having the structure

to a DC Building Block having the structure

to obtain EDC-Trimer-CB.

Assignments (8)
TERMINATION AND RELEASE OF SECURITY INTEREST IN PATENTS Recorded Nov 16, 2020
From: THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A.
To: AVANTOR PERFORMANCE MATERIALS, LLC; NUSIL TECHNOLOGY LLC; APPLIED SILICONE COMPANY LLC; RELIABLE BIOPHARMACEUTICAL, LLC; THERAPAK, LLC
Reel/Frame 054440/0877 →
SECURITY AGREEMENT (NOTES) Recorded Nov 6, 2020
From: AVANTOR FLUID HANDLING, LLC; AVANTOR PERFORMANCE MATERIALS, LLC; NUSIL TECHNOLOGY LLC; RELIABLE BIOPHARMACEUTICAL, LLC; THERAPAK, LLC
To: THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A., AS NOTES COLLATERAL AGENT
Reel/Frame 054343/0414 →
SECURITY AGREEMENT Recorded Nov 29, 2017
From: AVANTOR PERFORMANCE MATERIALS, LLC; NUSIL TECHNOLOGY LLC; APPLIED SILICONE COMPANY LLC; RELIABLE BIOPHARMACEUTICAL, LLC; THERAPAK, LLC
To: THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A., AS NOTES COLLATERAL AGENT
Reel/Frame 044528/0960 →
SECURITY AGREEMENT Recorded Nov 28, 2017
From: AVANTOR PERFORMANCE MATERIALS, LLC; NUSIL TECHNOLOGY LLC; APPLIED SILICONE COMPANY LLC; RELIABLE BIOPHARMACEUTICAL, LLC; THERAPAK, LLC
To: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
Reel/Frame 044811/0400 →
RELEASE (REEL 040913 / FRAME 0118) Recorded Nov 27, 2017
From: CITIBANK, N.A.
To: RELIABLE BIOPHARMACEUTICAL, LLC
Reel/Frame 044511/0265 →
SECURITY AGREEMENT Recorded Dec 14, 2016
From: RELIABLE BIOPHARMACEUTICAL, LLC
To: CITIBANK, N.A., AS COLLATERAL AGENT
Reel/Frame 040913/0118 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 10, 2016
From: RELIABLE BIOPHARMACEUTICAL CORPORATION
To: RELIABLE BIOPHARMACEUTICAL, LLC
Reel/Frame 040277/0548 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 31, 2016
From: RELIABLE BIOPHARMACEUTICAL CORPORATION
To: RELIABLE BIOPHARMACEUTICAL, LLC
Reel/Frame 040174/0564 →